Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-beta

Meng-Lu Liu1, Ming-Jie Liu, Yan-Fei Shen

  • 1Laboratory of Genetics, Department of Microbiology and Immunology and Institute for Medical Sciences, Chonbuk National University Medical School, Chonju 561-712, South Korea.

Insights

The serine protease Omi protects neurons from toxic amyloid-beta (Abeta) oligomers by disaggregating them. This Omi-Abeta interaction reduces neurotoxicity and Abeta accumulation, offering a potential therapeutic target for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Cellular Biology
  • Biochemistry

Background:

  • Metabolite accumulation causes cellular dysfunction and neurodegeneration.
  • Amyloid-beta (Abeta) oligomers are toxic to neurons, but intracellular levels are unclear.
  • The mechanisms by which neurons prevent Abeta-induced neurotoxicity are not fully understood.

Purpose of the Study:

  • To investigate the role of the serine protease Omi in the detoxification of intracellular oligomeric Abeta.
  • To elucidate the interaction between Omi and Abeta and its impact on neuroprotection.

Main Methods:

  • Immunochemical and biochemical studies were employed.
  • Analysis of Omi's binding specificity to different Abeta forms.
  • Investigation of Omi's function in disaggregating toxic Abeta oligomers.

Main Results:

  • Omi, a heat-shock protein, binds preferentially to toxic oligomeric Abeta via its PDZ domain.
  • Omi disaggregates oligomeric Abeta, reducing both Omi's pro-apoptotic activity and Abeta neurotoxicity.
  • Omi expression is upregulated during mouse neurogenesis and neuronal maturation, correlating with increased Abeta generation.

Conclusions:

  • Omi plays a crucial neuroprotective role by detoxifying intraneuronal oligomeric Abeta.
  • The Omi-PDZ domain interaction with Abeta is key to preventing neurodegeneration.
  • Omi represents a novel therapeutic target for neurodegenerative diseases.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...